...
首页> 外文期刊>Journal of Clinical Immunology >IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma.
【24h】

IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma.

机译:IL-9有助于由B细胞非霍奇金淋巴瘤中的调节性T细胞和肥大细胞介导的免疫抑制。

获取原文
获取原文并翻译 | 示例

摘要

It has been known that regulatory T (Treg) cells and mast cells (MCs) are involved in tumor immunity regulation, but the exact roles and mechanisms of Treg cells and MCs in B-cell non-Hodgkin's lymphoma (NHL) are incompletely defined. In the present study, we found that the number of Foxp3(+) Treg cells and CD117(+) MCs increased in B-cell NHL patients. Concomitantly, a high level of interleukin (IL)-9 was observed in the sera from B-cell NHL patients. Neutralizing IL-9 significantly inhibited tumor growth in the lymphoma model of murine, and this process was associated with down-regulation of Treg cells and MCs. Furthermore, IL-9 was also demonstrated to induce expression of MC-related genes and proliferation of MCs from the bone marrow stem cells. Collectively, our results indicate that Treg cell and MCs are involved in immunosuppression in B-cell NHL, and IL-9 is a key mediator of Treg cells and MCs in that process. These findings provide novel insight for the pathogenesis and possible therapeutic strategy of B-cell NHL.
机译:已知调节性T(Treg)细胞和肥大细胞(MCs)参与肿瘤免疫调节,但是Treg细胞和MCs在B细胞非霍奇金淋巴瘤(NHL)中的确切作用和机制尚不完全清楚。在本研究中,我们发现B细胞NHL患者中Foxp3(+)Treg细胞和CD117(+)MC的数量增加。同时,在B细胞NHL患者的血清中观察到高水平的白介素(IL)-9。在小鼠淋巴瘤模型中,中和IL-9可以显着抑制肿瘤的生长,并且该过程与Treg细胞和MC的下调有关。此外,IL-9还被证明可以诱导MC相关基因的表达和骨髓干细胞中MC的增殖。总体而言,我们的结果表明Treg细胞和MC参与了B细胞NHL的免疫抑制,而IL-9是该过程中Treg细胞和MC的关键介体。这些发现为B细胞NHL的发病机理和可能的治疗策略提供了新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号